AI’s role in making rare disease diagnosis more efficient

Run for Rare 2025: Let’s make every step count!

enGenome attending SPGH 2024 in Porto, Portugal

New VarChat Chatbot: interactive conversations for better insights

enGenome to showcase new breakthrough VarChat feature at ASHG 2024 in Denver

enGenome in Palermo for insights on AI in variant interpretation

enGenome to present at SIGU 2024 in Padova: AI innovations for more efficient analysis

enGenome Achieves ISO/IEC 27001:2022 Certification for Information Security, Cybersecurity and Privacy Protection

Unveiling the stigma of genetic discrimination

enGenome at ESHG 2024 to present Corporate Satellite with guest from Twist Bioscience

Commitment to Excellence: enGenome's Quality Policy

enGenome to showcase AI-driven solutions at ISV Conference in Porto, Portugal

ESHG Sneak peek: Finding order in genomic disorders with enGenome’s AI

enGenome invited to talk on AI to advance variant interpretation at HUGO 2024

enGenome’s Run for Rare to raise awareness for Rare Disease Day

Rare diseases: an overwhelming economic scenario

enGenome gets ready for the Festival of Genomics in London

enGenome takes the stage at PMWC in Silicon Valley

enGenome heads to Paris for Assises de Génétique Humaine et Médicale in 2024!

enGenome will attend CIGH 2023 in Málaga, Spain

enGenome launches VarChat: the first GenAI genomic variant assistant

eVai: Mastering Variant Interpretation in Diagnostics

enGenome presenting at SIGU 2023 in Rimini, Italy

enGenome invited to teach at PhD Week Course

enGenome's acceptance for a platform oral presentation at the ASHG in Washington, DC

Artificial Intelligence regulation and the future of clinical genomics

eVai now performs detection and interpretation of mitochondrial DNA variants!

enGenome supports Williams Syndrome Association by sponsoring a fundraiser Golf Tournament in New England, United States.

enGenome at Grandangolo 2023 in Rome

Mitochondrial DNA: the code powering the cell energy

ESHG 2023: enGenome to show AI-based variant interpretation at Corporate Satellite

From HGP to T2T: the foundation for a new genomic era

enGenome at GfH 2023 in Kassel, Germany

enGenome at ACMG 2023 in Salt Lake City

“We Care About Rare”: enGenome’s new campaign on Rare Disease

The Diagnostic Odyssey of rare diseases: the impact of an early and accurate diagnosis.

eVai is now fully equipped to perform variant interpretation seamlessly from FastQ!

Suggested Diagnosis: where machine-learning meets variant prioritization

Bando Brevetti 2021

enGenome at ASHG 2022 in Los Angeles

enGenome at SIGU 2022 in Trieste

Concessioni di contributi/finanziamenti pubblici

ESHG 2022: enGenome Solutions for Excellence in Variant Interpretation

enGenome’s eVai platform is a best performer in the NIH-funded CAGI6 Challenge

enGenome at Grandangolo Roma 2022

Rare Disease Day 2022: Marfan Syndrome

Rare Disease Day 2022: explaining RD to young children

S.Matteo Hospital – Hematology Oncology

enGenome at SIGU 2021 Virtual Meeting

enGenome among start-up champions to receive funding from European Innovation Council Accelerator

enGenome at ASHG 2021 Virtual Meeting

Digenic inheritance: a key mechanism for understanding rare diseases

ESHG 2021: Enhance your NGS variant analysis

Rapid WGS: the impact on newborns

Deep Intronic Mutations and Human Diseases

WES and WGS, a comparison of usage

The HPO: the importance of clinical coding in variant interpretation

enGenome and Unimib for Scientific Content Creator Project

Diagnostica oncologica e CNV: il workflow di analisi dati NGS

The right diagnosis is the first step to fight the Rare Disease battle

Bench to bedside: successful application of WES in the molecular diagnosis of genetic diseases

Copy Number Variations: beyond discovery

Business Forum Canada-Italy on AI

Medical College of Wisconsin

University of Pavia – Biotechnology Department

Gene Constraint Webinar

The Digital Genomic Era

eVai has qualified as an AgID certified supplier

Enabling accurate and fast variant analysis for the diagnosis of genetic diseases causing hearing loss

Consensus Assessment Initiative Questionnaire

eVai Webinar

The benefits of hypothesis-free interpretation to solve undiagnosed cases

enGenome at the SIGU 2019 in Rome

Tackling the bottleneck of Variant Interpretation

enGenome at the ASHG 2019 in Houston

Lung and colorectal cancer variant prioritization at Kabara Cancer Research Institute

The powerful ways Artificial Intelligence is reshaping the diagnosis of genetic disorders

enGenome at ESHG 2019 in Gothenburg

enGenome won G-factor Life Science Call

enGenome at ESHG 2018 in Milan

enGenome at SIGU 2017 in Naples

enGenome won Novartis Oncology award